小鼠胰岛α细胞选择性敲除Tcf7l2损害胰高血糖素分泌及低血糖反向调节反应
研究通过将floxed Tcf7l2等位基因小鼠与PPGCre转基因小鼠杂交,构建胰岛α细胞选择性Tcf7l2敲除(Tcf7l2AKO)小鼠,评估其对胰高血糖素分泌和低血糖反向调节的影响。结果显示Tcf7l2AKO小鼠葡萄糖耐量未受影响,但高胰岛素-低血糖钳夹试验中葡萄糖输注速率增加、胰高血糖素分泌倾向降低,离体胰岛低糖刺激下胰高血糖素释放受损,α细胞质量减少。结论提示Tcf7l2在α细胞自主调控胰高血糖素分泌及维持α细胞质量和功能中发挥作用。
要点
- Tcf7l2AKO小鼠葡萄糖耐量未受影响,但空腹血糖降低。
- 高胰岛素-低血糖钳夹中葡萄糖输注速率AUC增加1.98±0.26倍(p<0.05,n=6)。
- 离体胰岛低糖刺激下胰高血糖素释放为野生型的0.37±0.02倍(p<0.01,n=6)。
核心结论
- Tcf7l2在胰岛α细胞中自主调控胰高血糖素分泌并维持α细胞质量和功能。
研究设计与样本
- 将floxed Tcf7l2等位基因小鼠与携带preproglucagon启动子驱动的Cre重组酶转基因(PPGCre)小鼠杂交,获得胰岛α细胞选择性Tcf7l2敲除(Tcf7l2AKO)小鼠。
- 采用标准技术检测体内外葡萄糖稳态、激素分泌及胰岛细胞质量。
主要发现
- Tcf7l2AKO小鼠葡萄糖耐量未受影响。
- 高胰岛素-低血糖钳夹试验前60分钟葡萄糖AUC在Tcf7l2AKO小鼠较野生型增加1.98±0.26倍(p<0.05;n=6)。
- 血浆胰高血糖素在Tcf7l2AKO小鼠为野生型同窝对照的0.40±0.03倍(p<0.01;n=6),原文描述为倾向降低。
- Tcf7l2AKO小鼠空腹血浆葡萄糖浓度降低。
- 离体胰岛低糖刺激下胰高血糖素释放为野生型同窝对照胰岛的0.37±0.02倍(p<0.01;n=6)。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Transcription factor 7-like 2 (TCF7L2) is a high mobility group (HMG) box-containing transcription factor and downstream effector of the Wnt signalling pathway. SNPs in the TCF7L2 gene have previously been associated with an increased risk of type 2 diabetes in genome-wide association studies. In animal studies, loss of Tcf7l2 function is associated with defective islet beta cell function and survival. Here, we explore the role of TCF7L2 in the control of the counter-regulatory response to hypoglycaemia by generating mice with selective deletion of the Tcf7l2 gene in pancreatic alpha cells. METHODS: Alpha cell-selective deletion of Tcf7l2 was achieved by crossing mice with floxed Tcf7l2 alleles to mice bearing a Cre recombinase transgene driven by the preproglucagon promoter (PPGCre), resulting in Tcf7l2AKO mice. Glucose homeostasis and hormone secretion in vivo and in vitro, and islet cell mass were measured using standard techniques. RESULTS: While glucose tolerance was unaffected in Tcf7l2AKO mice, glucose infusion rates were increased (AUC for glucose during the first 60 min period of hyperinsulinaemic-hypoglycaemic clamp test was increased by 1.98 ± 0.26-fold [p < 0.05; n = 6] in Tcf7l2AKO mice vs wild-type mice) and glucagon secretion tended to be lower (plasma glucagon: 0.40 ± 0.03-fold vs wild-type littermate controls [p < 0.01; n = 6]). Tcf7l2AKO mice displayed reduced fasted plasma glucose concentration. Glucagon release at low glucose was impaired in islets isolated from Tcf7l2AKO mice (0.37 ± 0.02-fold vs islets from wild-type littermate control mice [p < 0.01; n = 6). Alpha cell mass was also reduced (72.3 ± 20.3% [p < 0.05; n = 7) in Tcf7l2AKO mice compared with wild-type mice. CONCLUSIONS/INTERPRETATION: The present findings demonstrate an alpha cell-autonomous role for Tcf7l2 in the control of pancreatic glucagon secretion and the maintenance of alpha cell mass and function.
引用
- da Silva Xavier G, Mondragon A, Mourougavelou V, et al. Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice. Diabetologia. 2017. PMID: 28343277. doi:10.1007/s00125-017-4242-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。